BDX · 10-Q · 2026Q2 · Full report
Trade Policy and Tariffs
BECTON DICKINSON & CO · 2026-08-06 · Importance 40 · Surprise 42 · In source text
Tariffs, sanctions and other trade barriers imposed by or against the United States adversely affected BD’s third-quarter fiscal 2026 operating expense and are expected to continue affecting fiscal 2026 and potentially later periods. The exposure primarily relates to products and components imported from countries across BD’s global supply chain that do not qualify for exemptions, with impacts also reflected in gross margins for the Medical Essentials, BioPharma Systems and Interventional segments. BD is pursuing sourcing optimization, tariff exemptions and refunds of certain tariffs, but the collectability of the remaining exemption-claim receivable remains uncertain because mitigation strategies could be challenged, rejected or eliminated.
Key facts
- Tariffs adversely impacted BD's third quarter fiscal year 2026 operating expense and BD expects a continued adverse impact to operating expense for fiscal year 2026 and potentially beyond based on latest published tariffs currently in effect. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | probable | — | Tariffs adversely impacted BD's third quarter fiscal year 2026 operating expense and BD expects a continued adverse impact to operating… |